Don’t miss out - Get your tickets early!

Join this free, 60-minute online webinar to gain access to insights and learn about ground breaking treatments to chronic mental health conditions.

Many have noted that the use of psychedelics seems to be experiencing a renaissance, and more and more research is finding substantial benefit in the use of psychedelics for mental health problems, such as depression and PTSD. These data suggest that one or two experiences with psychedelics can reliably produce a transformative experience that has lasting and positive benefits. This raises the question as to exactly what is happening. That is, is there a theory of the human mind that can provide a descriptive and even causal explanatory framework for these transformations?

This hour-long webinar will review a framework for higher transformative conscious experiences developed by Dr. John Vervaeke and situated in Dr. Gregg Henriques’ larger unified theory of psychology. This framework interprets transformational conscious experiences as stemming from deep changes in what Vervaeke calls “perspectival” and “participatory” forms of knowing.

This webinar will explain why, when appropriately set up and scaffolded, psychedelics may reliably produce this kind of change.

Learning Outcomes:

Learn about the three domains of human consciousness
Learn about the four ways of knowing
Learn what happens during transformational consciousness experiences
Will be able to describe why psychedelics may, when appropriately scaffolded, reliably result in transformational consciousness experiences

WEBINAR SESSION

Date: Thursday 30 July 2020
Time: 7:25pm for 7:30pm start – 8:30pm (incl Q&A) (AEST)

The presentation WILL BEGIN AT 7:30pm.

Location: Online. A link will be emailed to you with the viewing details.

Following the presentation there will be a Q & A panel with Professor Gregg Henriques (USA) and Tania de Jong AM. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

More about medicinal psychedelic treatments:

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

More about the presenters

Professor Gregg Henriques (USA)
PhD, MS, BS
Clinical Psychologist

Dr. Gregg Henriques is Professor of Graduate Psychology at James Madison University in the Combined-Integrated Doctoral Program in Clinical and School Psychology. Dr. Henriques received his Ph.D. in Clinical Psychology from the University of Vermont and did his post-doctoral training at the University of Pennsylvania. Dr. Henriques’ primary area of scholarly interest is in developing a “unified framework” for both the science and practice of psychology. He has authored the book, A New Unified Theory of Psychology and developed a popular blog on Psychology Today, Theory of Knowledge, where he has authored over 350 essays on psychology, philosophy, politics, and mental health. He is a Fellow of the American Psychological Association, has won numerous awards for teaching, scholarship, and service, and launched and leads the Theory of Knowledge academic society. He has expertise in theoretical psychology, unified approaches to psychotherapy, psychological well-being, personality functioning, depression, and suicidal behaviour.

Tania de Jong AM (Moderator)
LL.B (Hons), GradDipMus
Founder & Deputy Chair of Mind Medicine Australia

Tania de Jong AM is a trail-blazing Australian soprano, award-winning social entrepreneur, creative innovation catalyst, spiritual journey woman, storyteller and global speaker. Tania is one of Australia’s most successful female entrepreneurs and innovators developing 5 businesses and 3 charities over the past 3 decades. She is Founder and Executive Producer of future-shaping events series, Creative Innovation Global. She was appointed a Member of the Order of Australia in June 2008 and named one of the 100 Women of Influence and the 100 Australian Most Influential Entrepreneurs in 2018.

Support psychedelic research and therapy development

By donating to Mind Medicine Australia, you will be helping us to accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support.

Please click here to make a tax-deductible donation.

Disclaimer

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example facebook, instagram and zoom private and public chat forms during the webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.